Corporate Overview

  • AccuGenomics was founded in 2010 to develop standardized oncology molecular diagnostics
  • Intellectual property is based on technology licensed from University of Toledo. (35 patents & applications)
  • Over 10 years of development activities in association with previous University of Toledo collaborations and Innovative Molecular Analysis Technologies NIH Program
  • AccuGenomics corporate headquarters is located in Wilmington, North Carolina including development laboratory of over 4,000 square feet